Rho GDP-dissociation inhibitor 2

Rho GDP-dissociation inhibitor 2 (Rho GDI 2), encoded by ARHGDIB, is a regulatory protein that inhibits GDP dissociation from Rho family GTPases and prevents subsequent GTP binding, thereby controlling the activation state of these molecular switches (UniProt: P52566). This function is critical for regulating actin cytoskeleton reorganization mediated by Rho proteins, which underlies cellular processes including migration, morphology, and synaptic plasticity.

Rho GDI 2 is a ubiquitously expressed regulator of cytoskeletal dynamics with no specifically annotated disease associations in UniProt. However, dysregulation of Rho signaling has been implicated in neuroinflammation and neurodegeneration through effects on both neuronal and glial actin dynamics.

In Alzheimer's disease, Rho GDI 2 shows consistent upregulation in post-mortem AD brain tissue compared to age-matched controls (Chaparral AD proteomics), with a mean log2 fold-change of +1.13 across examined subcellular fractions. This elevation may reflect compensatory or pathological alterations in cytoskeletal dynamics associated with AD neurodegeneration, though the functional significance of increased Rho GDI 2 in AD remains to be determined.